dactinomycin and Lymphoma, Mantle-Cell

dactinomycin has been researched along with Lymphoma, Mantle-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Armitage, JO; Bosch, F; Campo, E; Chan, WC; Chiorazzi, M; Connors, JM; Delabie, J; Fisher, RI; Gascoyne, RD; Gibellini, F; Greiner, TC; Grogan, TM; Holte, H; Jaffe, ES; Kvaloy, S; Liu, H; Miller, TP; Montserrat, E; Muller-Hermelink, HK; Nakayama, K; Ott, G; Rosenwald, A; Smeland, EB; Staudt, LM; Tehrani, M; Vose, J; Weisenburger, DD; Wiestner, A; Wilson, WH; Wright, G	1

Other Studies

1 other study(ies) available for dactinomycin and Lymphoma, Mantle-Cell

Article	Year
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. Blood, 2007, Jun-01, Volume: 109, Issue:11 Topics: 3' Untranslated Regions; Antineoplastic Agents; Cell Proliferation; Cyclin D; Cyclins; Dactinomycin; Gene Deletion; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Mantle-Cell; Mutation; Point Mutation; Polyadenylation; Protein Isoforms; RNA, Messenger; Treatment Outcome	2007

Article

Year

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.

Blood, 2007, Jun-01, Volume: 109, Issue:11

Topics: 3' Untranslated Regions; Antineoplastic Agents; Cell Proliferation; Cyclin D; Cyclins; Dactinomycin; Gene Deletion; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Mantle-Cell; Mutation; Point Mutation; Polyadenylation; Protein Isoforms; RNA, Messenger; Treatment Outcome

2007